BioHarvest Sciences Inc.
BHST
$7.20
-$0.4621-6.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.86M | 7.28M | 6.54M | 6.03M | 5.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.86M | 7.28M | 6.54M | 6.03M | 5.34M |
| Cost of Revenue | 3.27M | 3.16M | 2.83M | 2.93M | 2.34M |
| Gross Profit | 4.60M | 4.12M | 3.71M | 3.10M | 3.00M |
| SG&A Expenses | 5.07M | 4.41M | 4.54M | 3.79M | 3.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.58M | 8.97M | 8.64M | 7.80M | 6.77M |
| Operating Income | -1.72M | -1.69M | -2.10M | -1.78M | -1.42M |
| Income Before Tax | -2.30M | -2.95M | -2.69M | -687.00K | -6.58M |
| Income Tax Expenses | 38.00K | 8.00K | -- | -- | -- |
| Earnings from Continuing Operations | -2.34M | -2.96M | -2.69M | -687.00K | -6.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.34M | -2.96M | -2.69M | -687.00K | -6.58M |
| EBIT | -1.72M | -1.69M | -2.10M | -1.78M | -1.42M |
| EBITDA | -1.32M | -1.57M | -1.75M | -1.42M | -1.22M |
| EPS Basic | -0.13 | -0.17 | -0.16 | -0.04 | -0.48 |
| Normalized Basic EPS | -0.08 | -0.11 | -0.10 | -0.03 | -0.30 |
| EPS Diluted | -0.13 | -0.17 | -0.16 | -0.04 | -0.48 |
| Normalized Diluted EPS | -0.08 | -0.11 | -0.10 | -0.03 | -0.30 |
| Average Basic Shares Outstanding | 17.33M | 17.34M | 17.34M | 16.35M | 13.75M |
| Average Diluted Shares Outstanding | 17.33M | 17.34M | 17.34M | 16.35M | 13.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |